ClinicalTrials.gg

Constipation clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,047 studies for Constipation across more than 10 countries. 161 are recruiting or about to start. 769 of them are mainly about Constipation (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Opioid-Induced Constipation too: 1,105 studies, 166 open.

ClinicalTrials.gov finds 1,259 studies for Constipation. How that becomes 1,044 here

This page counts the studies the registry files under Constipation, and those it files under no condition that list Constipationthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,259Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −58Filed under a narrower condition, counted on its own pageOpioid-Induced Constipation 55
  3. −71List Constipation as a condition, but the registry did not file them under itMost often written as “Functional Constipation” (16), “Constipation - Functional” (14), and “Irritable Bowel Syndrome With Constipation” (8). The registry filed them under other conditions only, most often Irritable Bowel Syndrome (19) and Gastroesophageal Reflux (5).
  4. −86Match it another way67 name it in the title, 12 in a keyword, and 7 by a synonym or other text the search reads.
  5. 1,044The count on this page237 of them list Constipation in their own words; the registry filed them under no condition.

Status

Completed
676
Status unknown
100
Recruiting
99
Not yet recruiting
57
Terminated
54
Withdrawn
27

Phase

Phase 2
169
Phase 3
150
Phase 4
105
Phase 1
54
Early Phase 1
8

Where

United States
345
China
109
Turkey
72
United Kingdom
61
Canada
50
France
42

Who develops what

Add Constipation to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 3 programs from 3 companies, 2 with this as their studies’ main aim; 1 with a live phase 3 study; 3 primary completions in the next 12 months. Compare Ardelyx, Bausch Health Companies and Eli Lilly here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

DrugLeading trial sponsor · rightsCompanies, last 5 years
polyethylene glycol 4000Earlier onlyPhase 4 trial recorded
Evidence
  • NCT02751411 · aboca spa societa agricola · Phase 4 · comparator · “Macrogol 4000” · registered Apr 2016
  • NCT02292459 · Bayer · Phase 3 · comparator · “Polyethylene Glycol 4000 Powder for Solution (PEG 4000)” · registered Nov 2014
  • NCT01330381 · Takeda · Phase 3 · comparator · “PEG 4000” · registered Apr 2011
  • NCT00603681 · Orion Corporation, Orion Pharma · Phase 4 · comparator · “Polyethylene glycol 4000 with electrolytes” · registered Jan 2008
Ipsen67% of its industry studies00 studies
prucaloprideEarlier only
Evidence
  • NCT02538367 · Yuhan Corporation · Phase 2 · comparator · “Prucalopride 2mg” · registered Aug 2015
  • NCT01251822 · Norgine · Phase 3 · comparator · “Prucalopride” · registered Nov 2010
Takeda93% of its industry studiesUS: off-patent, 14 generics marketedEU: Takeda (EMA 2009)00 studies

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 3 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (3)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 26 Feb 2027 est.tenapanor · Ardelyx · Phase 3 main aimNCT07382167 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults — primary endpoint: Durable complete spontaneous bowel movements (CSBM) response · 692 enrolled
  • Jul 2027 est.brenipatide · Eli Lilly and Company · Phase 2 named, not the main aimNCT07545772 A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C) — primary endpoint: Percentage of Participants with a Weekly Composite Clinical Response for at Least 50 Percent (%) of Weeks · 342 enrolled
  • 18 Oct 2027 est.plecanatide · Bausch Health Companies Inc. · Phase 2 main aimNCT07723924 This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FC — primary endpoint: Change From Baseline in Weekly Spontaneous Bowel Movement (SBM) Frequency at Week 8 · 180 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Constipation studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here SSRIs 2 open · Cholinesterase inhibitors 1 open · Serotonin receptor agonists 33 · Opioid antagonists 27 · Opioids 8

Coming up

60studies finish main data collection within a year5 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 99 Constipation studies recruiting now, 32 (32%) set no upper age limit and 52 (53%) stop at 75 or younger. 17 (17%) take children under 18. 12 (12%) are for women only and 1 (1%) for men only; 28 (28%) take healthy volunteers.

Recruiting studies that take each age, of 99
AgeWomenMen
1013 (13%)13 (13%)
1871 (72%)62 (63%)
3080 (81%)70 (71%)
4084 (85%)73 (74%)
5077 (78%)70 (71%)
6572 (73%)67 (68%)
7554 (55%)50 (51%)
8538 (38%)34 (34%)

Across all 1,047 studies, recruiting or not: 52% stop at 75 or younger and 38% at 65; 21% take children; 9% are for women only and 1% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Constipation studies take

Of 41 phase 2 interventional studies under Constipation, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 121 mo10–38 · 13 studies——
Phase 220 mo10–42 · 41 studies19 mo10–29 · 24 studies—
Phase 321 mo10–37 · 36 studies21 mo10–37 · 28 studies—
Phase 425 mo9–39 · 34 studies——
Interventional, no phase14 mo6–30 · 316 studies11 mo5–16 · 71 studies16 mo7–35 · 245 studies
Observational26 mo13–46 · 52 studies—26 mo12–46 · 42 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 17, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 1,047. Browse all 1,047 → or search them.